EMEA-000827-PIP01-09-M04
Key facts
Invented name |
Cayston
|
Active substance |
Aztreonam
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0064/2016
|
PIP number |
EMEA-000827-PIP01-09-M04
|
Pharmaceutical form(s) |
Powder and solvent for nebuliser solution
|
Condition(s) / indication(s) |
Treatment of Pseudomonas aeruginosa pulmonary infection / colonisation in patients with cystic fibrosis
|
Route(s) of administration |
Inhalation use
|
Contact for public enquiries |
Gilead Sciences International Limited
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|